The Oracle Health Sciences' Clinical One platform has been selected by Servier to make its vision of a next-generation clinical trial management environment a reality. To start and manage clinical trials is a lengthy and regulated process that entails mountains of data to account for and share with various stakeholders.
"We were looking for a technology platform that could enable us to innovate, modernize, and standardize our overall approach to clinical trials," said Patricia Belissa-Mathiot, Head of Clinical Development and R&D CMO at Servier Group. "Following a strict and thorough review process, it was clear that Oracle provided a comprehensive, unified platform with a robust data approach that could support our plan for an integrated and digitized environment. All of our processes – from study startup through conduct and close out – will be integrated and streamlined on the Oracle Clinical One platform. Our teams will now be able to follow, analyze data and draw valuable clinical insight—in a single place—which will ultimately help accelerate bringing our therapies to market to patients waiting in need."
Servier focuses on cardiovascular and metabolic diseases, oncology and immuno-inflammatory, and neurodegenerative diseases. The Clinical One platform will unify the Servier clinical environment to start new trials in a more efficient way, make mid-study changes in real-time, and unite everyone working on a trial – from CROs to sponsors – in a common data environment.
Servier has selected Clinical One for its shared capabilities and common functions, to unify its clinical environment, and shave weeks off of traditional clinical operations. Clinical One will enable significant business efficiencies from across the study lifecycle, including capabilities like study budgeting and forecasting, site selection and activation, randomization and trial supply, data collection and mHealth, and clinical and operational data management and analysis.
Servier also chose Clinical One for its ability to address various aspects of decentralized trials. The platform will ensure data collection from new and multiple data sources, harmonize the data, and eliminate reconciliation by having a single source of truth, drawing valuable clinical insights via dashboards and KPIs.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!